» Articles » PMID: 31469230

Characterization of the Beckwith-Wiedemann Spectrum: Diagnosis and Management

Abstract

Beckwith-Wiedemann syndrome (BWS) is the most common epigenetic overgrowth and cancer predisposition disorder. Due to both varying molecular defects involving chromosome 11p15 and tissue mosaicism, patients can present with a variety of clinical features, leading to the newly defined Beckwith-Wiedemann spectrum (BWSp). The BWSp can be further divided into three subsets of patients: those presenting with classic features, those presenting with isolated lateralized overgrowth (ILO) and those not fitting into the previous two categories, termed atypical BWSp. Previous reports of patients with BWS have focused on those with the more recognizable, classic features, and limited information is available on those who fit into the atypical and ILO categories. Here, we present the first cohort of patients recruited across the entire BWSp, describe clinical features and molecular diagnostic characteristics, and provide insight into practical diagnosis and management recommendations that we have gained from this cohort.

Citing Articles

Molecular and Clinical Features of Adrenocortical Tumors in Beckwith-Wiedemann Spectrum.

Carli D, Rondot F, Luca M, Campello A, Vallero S, Tirtei E Cancers (Basel). 2024; 16(23).

PMID: 39682154 PMC: 11640037. DOI: 10.3390/cancers16233967.


Morphometric measurements of intraoral anatomy in children with Beckwith-Wiedemann syndrome: a novel approach.

Romeo D, George A, Sussman J, Banala M, Wiemken A, Wu M Orphanet J Rare Dis. 2024; 19(1):384.

PMID: 39420401 PMC: 11483972. DOI: 10.1186/s13023-024-03350-3.


Update on Surveillance for Wilms Tumor and Hepatoblastoma in Beckwith-Wiedemann Syndrome and Other Predisposition Syndromes.

Kalish J, Becktell K, Bougeard G, Brodeur G, Diller L, Doria A Clin Cancer Res. 2024; 30(23):5260-5269.

PMID: 39320341 PMC: 11611621. DOI: 10.1158/1078-0432.CCR-24-2100.


Pediatric Adrenocortical Carcinoma: The Nuts and Bolts of Diagnosis and Treatment and Avenues for Future Discovery.

ONeill A, Ribeiro R, Pinto E, Clay M, Zambetti G, Orr B Cancer Manag Res. 2024; 16:1141-1153.

PMID: 39263332 PMC: 11389717. DOI: 10.2147/CMAR.S348725.


Phenotypic spectrum and tumor risk in Simpson-Golabi-Behmel syndrome: Case series and comprehensive literature review.

Nisbet A, Viswanathan A, George A, Arias P, Klein S, Nevado J Am J Med Genet A. 2024; 194(12):e63840.

PMID: 39158128 PMC: 11540722. DOI: 10.1002/ajmg.a.63840.


References
1.
Hoyme H, Seaver L, Jones K, Procopio F, Crooks W, Feingold M . Isolated hemihyperplasia (hemihypertrophy): report of a prospective multicenter study of the incidence of neoplasia and review. Am J Med Genet. 1998; 79(4):274-8. View

2.
Brioude F, Lacoste A, Netchine I, Vazquez M, Auber F, Audry G . Beckwith-Wiedemann syndrome: growth pattern and tumor risk according to molecular mechanism, and guidelines for tumor surveillance. Horm Res Paediatr. 2013; 80(6):457-65. DOI: 10.1159/000355544. View

3.
Duffy K, Deardorff M, Kalish J . The utility of alpha-fetoprotein screening in Beckwith-Wiedemann syndrome. Am J Med Genet A. 2017; 173(3):581-584. PMC: 5928504. DOI: 10.1002/ajmg.a.38068. View

4.
Alders M, Maas S, Kadouch D, van der Lip K, Bliek J, van der Horst C . Methylation analysis in tongue tissue of BWS patients identifies the (EPI)genetic cause in 3 patients with normal methylation levels in blood. Eur J Med Genet. 2014; 57(6):293-7. DOI: 10.1016/j.ejmg.2014.03.011. View

5.
Mackay D, Bliek J, Lombardi M, Russo S, Calzari L, Guzzetti S . Discrepant molecular and clinical diagnoses in Beckwith-Wiedemann and Silver-Russell syndromes. Genet Res (Camb). 2019; 101:e3. PMC: 7044970. DOI: 10.1017/S001667231900003X. View